TALARIS THERAPEUTICS INC shareholders Q3 2023

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

TALARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
FREEDOM WEALTH ALLIANCE, LLC 16,145$45,3670.08%
Marquette Asset Management, LLC 40,028$112,4790.03%
Avoro Capital Advisors LLC 500,000$1,405,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 301,175$846,3020.02%
XTX Topco Ltd 21,651$60,8390.01%
BALYASNY ASSET MANAGEMENT L.P. 1,465,602$4,118,3420.01%
TWO SIGMA INVESTMENTS, LP 246,030$691,3440.00%
TWO SIGMA ADVISERS, LP 226,627$636,8220.00%
Walleye Capital LLC 262,469$737,5380.00%
Renaissance Technologies 196,465$5520.00%
External links

This page lists TALARIS THERAPEUTICS INC's shareholders in Q3 2023. To view TALARIS THERAPEUTICS INC's shareholder history, click here.